RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

Case report: One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/ca7c692c1c8b4fd293e21fb74c5a9057
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:ca7c692c1c8b4fd293e21fb74c5a9057
record_format	dspace
spelling	oai:doaj.org-article:ca7c692c1c8b4fd293e21fb74c5a90572021-11-10T04:37:30ZRECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)2531-137910.1016/j.htct.2021.10.1057https://doaj.org/article/ca7c692c1c8b4fd293e21fb74c5a90572021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2531137921012049https://doaj.org/toc/2531-1379Case report: One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are consistent with AIHA recurrence. Splenectomy was performed after the patient stabilized with rituximab therapy. Especially newly developed therapeutic agents have a potential risk of new side effects.Fatma YILMAZMurat ALBAYRAKMerih REİS ARASSenem MARALHacer Berna AFACAN ÖZTÜRKPınar TIĞLIOĞLUMesut TIĞLIOĞLUBuğra SAĞLAMElsevierarticleDiseases of the blood and blood-forming organsRC633-647.5ENHematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S50- (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the blood and blood-forming organs RC633-647.5
spellingShingle	Diseases of the blood and blood-forming organs RC633-647.5 Fatma YILMAZ Murat ALBAYRAK Merih REİS ARAS Senem MARAL Hacer Berna AFACAN ÖZTÜRK Pınar TIĞLIOĞLU Mesut TIĞLIOĞLU Buğra SAĞLAM RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
description	Case report: One of the causes of autoimmune hemolytic anemia is drugs. Vaccination is the most important step in the management of the COVID-19 pandemic. After receiving the m-RNA COVID-19 (Pfizer-BioNTech) vaccine, the patient admitted with weakness and jaundice for the last three days. Laboratory results are consistent with AIHA recurrence. Splenectomy was performed after the patient stabilized with rituximab therapy. Especially newly developed therapeutic agents have a potential risk of new side effects.
format	article
author	Fatma YILMAZ Murat ALBAYRAK Merih REİS ARAS Senem MARAL Hacer Berna AFACAN ÖZTÜRK Pınar TIĞLIOĞLU Mesut TIĞLIOĞLU Buğra SAĞLAM
author_facet	Fatma YILMAZ Murat ALBAYRAK Merih REİS ARAS Senem MARAL Hacer Berna AFACAN ÖZTÜRK Pınar TIĞLIOĞLU Mesut TIĞLIOĞLU Buğra SAĞLAM
author_sort	Fatma YILMAZ
title	RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_short	RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_full	RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_fullStr	RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_full_unstemmed	RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)
title_sort	recurrent autoimmune hemolytic anemia after mrna covid-19 vaccine (pfizer-biontech)
publisher	Elsevier
publishDate	2021
url	https://doaj.org/article/ca7c692c1c8b4fd293e21fb74c5a9057
work_keys_str_mv	AT fatmayilmaz recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech AT muratalbayrak recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech AT merihreisaras recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech AT senemmaral recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech AT hacerbernaafacanozturk recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech AT pınartiglioglu recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech AT mesuttiglioglu recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech AT bugrasaglam recurrentautoimmunehemolyticanemiaaftermrnacovid19vaccinepfizerbiontech
_version_	1718440598122266624

RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

Ejemplares similares